Search - tctmd.com

Displaying 21 - 40 of 367

Sort: Relevancy | Date

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

Caitlin E. Cox

July 21, 2025

News Daily News

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

Michael O'Riordan

July 18, 2025

News Opinion CV Team Dispatch

June 2025 Dispatch for the CV Team

L.A. McKeown

June 26, 2025

News Daily News

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Michael O'Riordan

June 25, 2025

News Conference News ESOC 2025

Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain

Todd Neale

May 28, 2025

News Daily News

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

Caitlin E. Cox

May 27, 2025

News Conference News ESOC 2025

IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

Todd Neale

May 22, 2025

News Daily News

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

L.A. McKeown

May 16, 2025

News Conference News European Congress on Obesity 2025

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Michael O'Riordan

May 13, 2025

News Conference News EAS 2025

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Yael L. Maxwell

May 08, 2025

News Daily News

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Michael O'Riordan

May 07, 2025

News Daily News

Access to GLP-1 Drugs Unequal for US Patients With Obesity

Caitlin E. Cox

May 01, 2025

News Opinion CV Team Dispatch

April 2025 Dispatch for the CV Team

L.A. McKeown

April 18, 2025

News Daily News

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

Yael L. Maxwell

April 16, 2025

News Conference News ACC 2025

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

L.A. McKeown

April 10, 2025

News Conference News ACC 2025

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

L.A. McKeown

April 03, 2025

News Opinion CV Team Dispatch

March 2025 Dispatch for the CV Team

L.A. McKeown

March 21, 2025

News Conference News CRT 2025

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

L.A. McKeown

March 12, 2025

Advertisement

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

GLP-1s May Stave Off Dementia, EHR-Based Study Shows

PREVENT Risk Calculator’s Accuracy Varies by Healthcare System, Patient Factors

June 2025 Dispatch for the CV Team

Heart Disease Deaths Decline Over Last 50 Years, but Not Across the Board

Less Intense Checks May Be OK After IV Thrombolysis for Stroke: OPTIMISTmain

What’s the Damage With Long COVID? Advanced Imaging Reveals Clues

IV Tenecteplase Helps Before Stroke Thrombectomy: BRIDGE-TNK

Apixaban Bests Rivaroxaban, Warfarin in Preventing VTE Recurrence and Bleeding

App-Based Support Aids Weight Loss With Semaglutide, Studies Show

Back From the Brink: Obicetrapib Performs Well in BROADWAY, TANDEM

Inclisiran Effective as Monotherapy for Lower-Risk Primary Prevention

Access to GLP-1 Drugs Unequal for US Patients With Obesity

April 2025 Dispatch for the CV Team

High-Sensitivity Troponin Tests Might Aid in Primary Prevention

ALPACA: Injectable siRNA Agent Safe and Effective for Lowering Lp(a)

FAIR-HF2: Another IV Iron Trial Fails to Impact Hard Endpoints

March 2025 Dispatch for the CV Team

Need for Rethink of Discharge Medications After LAA Closure? EMERGE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content